Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA

Acquired resistance is a major problem in cancer immunotherapy. Here the authors report a study of two patients with Merkel cell carcinoma under immunotherapy treatment who develop resistance after deep responses for >1 year and identified a novel mechanism of acquired, gene-specific transcriptio...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: K. G. Paulson, V. Voillet, M. S. McAfee, D. S. Hunter, F. D. Wagener, M. Perdicchio, W. J. Valente, S. J. Koelle, C. D. Church, N. Vandeven, H. Thomas, A. G. Colunga, J. G. Iyer, C. Yee, R. Kulikauskas, D. M. Koelle, R. H. Pierce, J. H. Bielas, P. D. Greenberg, S. Bhatia, R. Gottardo, P. Nghiem, A. G. Chapuis
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
Q
Acceso en línea:https://doaj.org/article/473d7b036b4c408a879dd4df2f3e7eb3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:473d7b036b4c408a879dd4df2f3e7eb3
record_format dspace
spelling oai:doaj.org-article:473d7b036b4c408a879dd4df2f3e7eb32021-12-02T14:40:06ZAcquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA10.1038/s41467-018-06300-32041-1723https://doaj.org/article/473d7b036b4c408a879dd4df2f3e7eb32018-09-01T00:00:00Zhttps://doi.org/10.1038/s41467-018-06300-3https://doaj.org/toc/2041-1723Acquired resistance is a major problem in cancer immunotherapy. Here the authors report a study of two patients with Merkel cell carcinoma under immunotherapy treatment who develop resistance after deep responses for >1 year and identified a novel mechanism of acquired, gene-specific transcriptional suppression of HLAs.K. G. PaulsonV. VoilletM. S. McAfeeD. S. HunterF. D. WagenerM. PerdicchioW. J. ValenteS. J. KoelleC. D. ChurchN. VandevenH. ThomasA. G. ColungaJ. G. IyerC. YeeR. KulikauskasD. M. KoelleR. H. PierceJ. H. BielasP. D. GreenbergS. BhatiaR. GottardoP. NghiemA. G. ChapuisNature PortfolioarticleScienceQENNature Communications, Vol 9, Iss 1, Pp 1-10 (2018)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
K. G. Paulson
V. Voillet
M. S. McAfee
D. S. Hunter
F. D. Wagener
M. Perdicchio
W. J. Valente
S. J. Koelle
C. D. Church
N. Vandeven
H. Thomas
A. G. Colunga
J. G. Iyer
C. Yee
R. Kulikauskas
D. M. Koelle
R. H. Pierce
J. H. Bielas
P. D. Greenberg
S. Bhatia
R. Gottardo
P. Nghiem
A. G. Chapuis
Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA
description Acquired resistance is a major problem in cancer immunotherapy. Here the authors report a study of two patients with Merkel cell carcinoma under immunotherapy treatment who develop resistance after deep responses for >1 year and identified a novel mechanism of acquired, gene-specific transcriptional suppression of HLAs.
format article
author K. G. Paulson
V. Voillet
M. S. McAfee
D. S. Hunter
F. D. Wagener
M. Perdicchio
W. J. Valente
S. J. Koelle
C. D. Church
N. Vandeven
H. Thomas
A. G. Colunga
J. G. Iyer
C. Yee
R. Kulikauskas
D. M. Koelle
R. H. Pierce
J. H. Bielas
P. D. Greenberg
S. Bhatia
R. Gottardo
P. Nghiem
A. G. Chapuis
author_facet K. G. Paulson
V. Voillet
M. S. McAfee
D. S. Hunter
F. D. Wagener
M. Perdicchio
W. J. Valente
S. J. Koelle
C. D. Church
N. Vandeven
H. Thomas
A. G. Colunga
J. G. Iyer
C. Yee
R. Kulikauskas
D. M. Koelle
R. H. Pierce
J. H. Bielas
P. D. Greenberg
S. Bhatia
R. Gottardo
P. Nghiem
A. G. Chapuis
author_sort K. G. Paulson
title Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA
title_short Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA
title_full Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA
title_fullStr Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA
title_full_unstemmed Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA
title_sort acquired cancer resistance to combination immunotherapy from transcriptional loss of class i hla
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/473d7b036b4c408a879dd4df2f3e7eb3
work_keys_str_mv AT kgpaulson acquiredcancerresistancetocombinationimmunotherapyfromtranscriptionallossofclassihla
AT vvoillet acquiredcancerresistancetocombinationimmunotherapyfromtranscriptionallossofclassihla
AT msmcafee acquiredcancerresistancetocombinationimmunotherapyfromtranscriptionallossofclassihla
AT dshunter acquiredcancerresistancetocombinationimmunotherapyfromtranscriptionallossofclassihla
AT fdwagener acquiredcancerresistancetocombinationimmunotherapyfromtranscriptionallossofclassihla
AT mperdicchio acquiredcancerresistancetocombinationimmunotherapyfromtranscriptionallossofclassihla
AT wjvalente acquiredcancerresistancetocombinationimmunotherapyfromtranscriptionallossofclassihla
AT sjkoelle acquiredcancerresistancetocombinationimmunotherapyfromtranscriptionallossofclassihla
AT cdchurch acquiredcancerresistancetocombinationimmunotherapyfromtranscriptionallossofclassihla
AT nvandeven acquiredcancerresistancetocombinationimmunotherapyfromtranscriptionallossofclassihla
AT hthomas acquiredcancerresistancetocombinationimmunotherapyfromtranscriptionallossofclassihla
AT agcolunga acquiredcancerresistancetocombinationimmunotherapyfromtranscriptionallossofclassihla
AT jgiyer acquiredcancerresistancetocombinationimmunotherapyfromtranscriptionallossofclassihla
AT cyee acquiredcancerresistancetocombinationimmunotherapyfromtranscriptionallossofclassihla
AT rkulikauskas acquiredcancerresistancetocombinationimmunotherapyfromtranscriptionallossofclassihla
AT dmkoelle acquiredcancerresistancetocombinationimmunotherapyfromtranscriptionallossofclassihla
AT rhpierce acquiredcancerresistancetocombinationimmunotherapyfromtranscriptionallossofclassihla
AT jhbielas acquiredcancerresistancetocombinationimmunotherapyfromtranscriptionallossofclassihla
AT pdgreenberg acquiredcancerresistancetocombinationimmunotherapyfromtranscriptionallossofclassihla
AT sbhatia acquiredcancerresistancetocombinationimmunotherapyfromtranscriptionallossofclassihla
AT rgottardo acquiredcancerresistancetocombinationimmunotherapyfromtranscriptionallossofclassihla
AT pnghiem acquiredcancerresistancetocombinationimmunotherapyfromtranscriptionallossofclassihla
AT agchapuis acquiredcancerresistancetocombinationimmunotherapyfromtranscriptionallossofclassihla
_version_ 1718390411539513344